Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?

Author： Krol Marieke   Brouwer Werner   Sendi Pedram  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.4, 2006-01, pp. : 401-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Productivity Costs Matter?: The Impact of Including Productivity Costs on the Incremental Costs of Interventions Targeted at Depressive Disorders

By Krol Marieke   Papenburg Jocé   Koopmanschap Marc   Brouwer Werner  

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 601-619

Adis International

Access to resources Recommend Favorite

The Pharmacology of New Antiepileptic Drugs: Does a Novel Mechanism of Action Really Matter?

By Perucca Emilio  

CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. : 907-912

Adis International

Access to resources Recommend Favorite

The Pharmacology and Clinical Outcomes of Amphetamines to Treat ADHD: Does Composition Matter?

By Hodgkins Paul  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 245-268

Adis International

Access to resources Recommend Favorite

Does Seropositivity for Helicobacter pylori Antibodies Increase Outpatient Costs for Gastric and Duodenal Ulcer or Inflammation?

By Akira Babazono   Motonobu Miyazaki  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 975-983

Adis International

Access to resources Recommend Favorite

Is DM a recipe for containing costs?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 271, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite